Home Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute
 

Keywords :   


Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute

2016-03-25 15:53:27| Biotech - Topix.net

The damages award is far less than the $2 billion Merck had demanded. On Tuesday, the same jury in San Jose, California, upheld the validity of the patents, which lie at the heart of the dispute over Gilead's blockbuster drugs Sovaldi and Harvoni.

Tags: pay million drug ordered

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
29.06Weekly Recap: PPG, Hempel, Beckers Group Top This Weeks Stories
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 3
29.06Tropical Storm Beryl Public Advisory Number 3
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 3
29.06Tropical Storm Beryl Forecast Advisory Number 3
29.06Eastern North Pacific Tropical Weather Outlook
More »